These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10818852)

  • 1. Noninvasive means of identifying fetuses with possible Down syndrome: a review.
    Kubas C
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):27-46. PubMed ID: 10818852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
    Nyberg DA; Luthy DA; Cheng EY; Sheley RC; Resta RG; Williams MA
    Am J Obstet Gynecol; 1995 Oct; 173(4):1030-5. PubMed ID: 7485289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of trisomy 21 in monozygotic twins with increased nuchal translucency and abnormal serum biochemistry.
    Verdin SM; Braithwaite JM; Spencer K; Economides DL
    Fetal Diagn Ther; 1997; 12(3):153-5. PubMed ID: 9313073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester genetic sonogram for detection of fetal chromosomal abnormalities in a community-based antenatal testing unit.
    Bottalico JN; Chen X; Tartaglia M; Rosario B; Yarabothu D; Nelson L
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):161-8. PubMed ID: 19173242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone.
    Bethune M
    Australas Radiol; 2007 Jun; 51(3):218-25. PubMed ID: 17504311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal chromosome analysis today. Screening by maternal age or serum test?
    Salonen R
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):146-7. PubMed ID: 7682376
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
    Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
    Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome.
    Smith-Bindman R; Chu P; Goldberg JD
    Prenat Diagn; 2007 Jun; 27(6):535-44. PubMed ID: 17367102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy.
    Nyberg DA; Souter VL; El-Bastawissi A; Young S; Luthhardt F; Luthy DA
    J Ultrasound Med; 2001 Oct; 20(10):1053-63. PubMed ID: 11587012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of Risk Factors in Down Syndrome Pregnancies.
    Hussamy DJ; Herrera CL; Twickler DM; Mcintire DD; Dashe JS
    Am J Perinatol; 2019 Jan; 36(1):79-85. PubMed ID: 30016823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ultrasound in screening for fetal Down syndrome.
    Egan JF
    Curr Womens Health Rep; 2002 Feb; 2(1):52-8. PubMed ID: 12112983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.
    Kloza EM
    Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
    Tercanli S; Vial Y; Merz E
    Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptability of serum screening as an alternative to cytogenetic diagnosis of down syndrome among women 35 years or older in Hong Kong.
    Lam YH; Tang MH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF
    Prenat Diagn; 2000 Jun; 20(6):487-90. PubMed ID: 10861714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic sonography after first-trimester Down syndrome screening.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.